Seer (SEER) Preferred Shares Issued (2020)

Seer (SEER) recorded quarterly Preferred Shares Issued of -$79000.0 in Q3 2020.

Seer (SEER) Preferred Shares Issued (2020) Analysis & Trends

Seer's Preferred Shares Issued history runs 1 years deep, the most recent figure standing at -$79000.0 for Q3 2020.

In Q3 2020, Preferred Shares Issued changed N/A year-over-year to -$79000.0; the TTM figure through Dec 2021 stood at -$79000.0 (changed N/A YoY), while the FY2020 annual figure was $54.9 million, changed N/A from the prior year.
Preferred Shares Issued was -$79000.0 for Q3 2020 at Seer.
In the past five years, Preferred Shares Issued ranged from a high of -$79000.0 in Q3 2020 to a low of -$79000.0 in Q3 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares Issued (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-	-
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-	-
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn	-
9	Abivax	95.45 Bn	95.45 Bn	-	-
10	Seer	95.75 Mn	95.75 Mn	982,000.00	-

Historic Data

Download Data

Date	Value
Sep 30, 2020	-79,000.00
Sep 30, 2020	-79,000.00